# Gne-Depletion in C2C12 Myoblasts Leads to Alterations in Glycosylation and Myopathogene Expression

**Authors:** Carolin T. Neu, Aristotelis Antonopoulos, Anne Dell, Stuart M. Haslam, Rüdiger Horstkorte

PMC · DOI: 10.3390/cells15020199 · Cells · 2026-01-20

## TL;DR

Reducing GNE in muscle cells changes glycosylation patterns and affects genes important for muscle function and energy metabolism.

## Contribution

This study reveals how GNE depletion alters glycosylation and downregulates key muscle-related genes in a C2C12 cell model.

## Key findings

- GNE depletion leads to changes in glycosaminoglycan expression and O-GlcNAcylation but not N-glycan remodeling.
- Muscle-specific genes like Scn4a, Cacna1s, Ryr1, and Pygm are downregulated in Gne knockout cells.
- Altered glycosylation may impair muscle signaling, excitability, and glucose metabolism.

## Abstract

GNE myopathy is a rare genetic neuromuscular disorder caused by mutations in the GNE gene. The respective gene product, UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE), is a bifunctional enzyme that initiates endogenous sialic acid biosynthesis. Sialic acids are important building blocks for the glycosylation machinery of cells and are typically found at the terminal ends of glycoprotein N- and O-glycans. The exact pathomechanism of GNE myopathy remains elusive, and a better understanding of the disease is urgently needed for the development of therapeutic strategies. The purpose of this study was to examine the effects of hyposialylation on glycan structures and subsequent downstream effects in the C2C12 Gne knockout cell model. No overall remodeling of N-glycans was observed in the absence of Gne, but differences in glycosaminoglycan expression and O-GlcNAcylation were detected. Expression analysis of myopathogenes revealed concomitant down-regulation of muscle-specific genes. Among the top candidates were the sodium channel protein type 4 subunit α (Scn4a), voltage-dependent L-type calcium channel subunit α-1s (Cacna1s), ryanodine receptor 1 (Ryr1), and glycogen phosphorylase (Pygm), which are associated with excitation-contraction coupling and energy metabolism. The results suggest that remodeling of the glycome could have detrimental effects on intracellular signaling, excitability of skeletal muscle tissue, and glucose metabolism.

## Linked entities

- **Genes:** GNE (glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase) [NCBI Gene 10020], SCN4A (sodium voltage-gated channel alpha subunit 4) [NCBI Gene 6329], CACNA1S (calcium voltage-gated channel subunit alpha1 S) [NCBI Gene 779], RYR1 (ryanodine receptor 1) [NCBI Gene 6261], PYGM (glycogen phosphorylase, muscle associated) [NCBI Gene 5837]
- **Diseases:** GNE myopathy (MONDO:0011603)

## Full-text entities

- **Genes:** Scn4a (sodium channel, voltage-gated, type IV, alpha) [NCBI Gene 110880] {aka Nav1.4, SkM1, mH2}, Cacna1s (calcium channel, voltage-dependent, L type, alpha 1S subunit) [NCBI Gene 12292] {aka Cav1.1, Cchl1a3, DHPR, DHPR alpha1s, fmd, mdg}, Pygm (muscle glycogen phosphorylase) [NCBI Gene 19309] {aka PG}, Ryr1 (ryanodine receptor 1, skeletal muscle) [NCBI Gene 20190] {aka RYR-1, Ryr, skrr}, Gne (glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase) [NCBI Gene 50798] {aka 2310066H07Rik, DMRV, GLCNE, IBM2, NM, Uae1}
- **Diseases:** genetic neuromuscular disorder (MESH:D030342), GNE myopathy (MESH:D009084)
- **Chemicals:** glucose (MESH:D005947), glycosaminoglycan (MESH:D006025), N- and O-glycans (-), sialic acid (MESH:D019158), Sialic acids (MESH:D012794)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12839626/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12839626/full.md

## References

31 references — full list in the complete paper: https://tomesphere.com/paper/PMC12839626/full.md

---
Source: https://tomesphere.com/paper/PMC12839626